Shook, Hardy & Bacon

Shook, Hardy & Bacon is an American law firm known for its defense work in product liability, pharmaceutical, and tobacco litigation. The firm rose to prominence through major national trials involving corporations and has maintained a presence in appellate and public policy matters. It represents clients across a range of industries and maintains offices in multiple U.S. and international jurisdictions.

History

Founded in 1889 in Kansas City, Missouri during a period of rapid urban growth alongside firms such as Baker McKenzie and contemporaries like Sullivan & Cromwell, the firm developed through the late 19th and 20th centuries into a national litigation practice. In the mid-20th century, amidst legal developments influenced by decisions from the Supreme Court of the United States and statutes like the Federal Rules of Civil Procedure, the firm expanded its trial capabilities. By the late 20th century, high-profile mass torts and regulatory disputes paralleled litigation handled by firms such as Kirkland & Ellis and Covington & Burling, positioning the firm as a key defender in product-liability and regulatory matters. The firm’s timeline intersects with national controversies involving companies represented by firms like Jones Day and Skadden, Arps, Slate, Meagher & Flom.

Practice Areas and Notable Cases

The firm has a concentrated practice in product liability, pharmaceutical defense, and tobacco litigation, engaging in trials and appeals overseen by courts such as the United States Court of Appeals for the Eighth Circuit and the Supreme Court of Missouri. In the tobacco litigation era, the firm operated in the milieu shaped by litigation against companies analogous to Philip Morris USA, R.J. Reynolds Tobacco Company, and suits that led to agreements similar in scope to the Master Settlement Agreement. In pharmaceutical and medical device defense, cases brought in venues like the United States District Court for the Southern District of New York and the United States District Court for the District of New Jersey often involved regulatory contexts related to the Food and Drug Administration and statutes compared to the Food, Drug, and Cosmetic Act.

Product-liability matters included defense work in trials and multidistrict litigation resembling cases before the United States Judicial Panel on Multidistrict Litigation and bellwether proceedings akin to high-profile disputes handled by firms such as Quinn Emanuel Urquhart & Sullivan and Morgan, Lewis & Bockius. Appellate advocacy has led the firm to argue in appellate tribunals from the United States Court of Appeals for the Second Circuit to the Eighth Circuit and to submit briefs in cases touching on precedents like those found in decisions from the Supreme Court of the United States.

Organizational Structure and Offices

Structured as a limited liability partnership, the firm’s leadership model has included managing partners and department chairs mirroring governance models at firms like DLA Piper and Latham & Watkins. The firm maintains offices in metropolitan centers including Washington, D.C., New York City, Los Angeles, Houston, and international offices in locations comparable to London and Brussels for global regulatory work. Practice groups are organized around litigation teams, appellate lawyers, and regulatory specialists who collaborate with in-house counsel from corporations such as General Motors, Bayer, and Johnson & Johnson on complex matters. Recruitment and alumni networks link the firm to former clerks of the United States Court of Appeals for the Seventh Circuit and the Supreme Court of the United States as well as to practitioners who later joined institutions like Harvard Law School and Georgetown University Law Center.

Pro Bono, Ethics, and Public Policy Involvement

The firm has engaged in pro bono representation in matters resembling civil-rights litigation before the United States District Court for the Western District of Missouri and immigration-related matters in tribunals comparable to the Board of Immigration Appeals. Its attorneys have participated in professional organizations such as the American Bar Association and served on advisory panels involved with agencies like the Food and Drug Administration and legislative committees in Congress. Ethical discussions around litigation strategy and client representation have intersected with commentary from commentators at outlets like The New York Times and legal scholars from Yale Law School and Columbia Law School.

Recognition and Criticism

The firm has received recognition in directories and rankings akin to those published by Chambers and Partners and The Legal 500 for its litigation and appellate work, and individual attorneys have been honored by organizations such as the American College of Trial Lawyers. Criticism has arisen in public discourse and academic commentary comparable to critiques published in The New York Times and The Washington Post regarding defense strategies in high-profile corporate litigation, echoing debates that have involved firms like Sidley Austin and Hogan Lovells. Scholarly analysis from institutions including Stanford Law School and University of Chicago Law School has examined the broader implications of mass-tort defense and regulation that frame the firm’s public profile.

Category:Law firms based in Missouri